Does OKT3 monoclonal antibody react with an antigen-recognition structure on human T cells?

AUTOR(ES)

Chang, T W

RESUMO

OKT3 monoclonal antibody to human T cells inhibits the target cell lysis mediated by allogeneic cytotoxic T cells and the generation of these effector cells in mixed lymphocyte culture. This marked inhibition of cell-mediated lysis is not found with other monoclonal antibodies also reactive with cell surface antigens of human T cells (OKT1, OKT4, OKT5, OKT6, OKT8, and OKT11). OKT3 antibody is mitogenic and this effect appears to require receptor activation in that it occurs at low concentrations (10(-12) M range) of OKT3 antibody, requires intact OKT3 IgG, and is inhibited by a factor(s) in human plasma. By contrast, the inhibition of allogeneic cell-mediated lysis by OKT3 antibody appears to be due to steric hindrance in that it requires higher concentrations of OKT3 antibody (10(-8) M range), Fab fragments retain approximately 10% activity, and inhibition is demonstrable in the presence of human plasma. These findings are consistent with the suggestion that OKT3 antibody reacts with the human T-cell antigen-recognition structure.

Documentos Relacionados

• Maintenance of antigen specificity by human interleukin-2-dependent T cell lines. Use of antigen-presenting cells and OKT3 antibody in the absence of antigen.
• Lymphokine-activated-killer-mediated lysis of cells infected with typhus group rickettsiae can be inhibited by OKT3 monoclonal antibody.
• Active Lymphocytic Myocarditis Treated with Murine OKT3 Monoclonal Antibody: in a Patient Presenting with Intractable Ventricular Tachycardia
• Infections in Patients Receiving OKT3 Monoclonal Antibody for Cardiac Rejection: Results of a Small Clinical Trial
• Crystal structure of the human T cell receptor CD3εγ heterodimer complexed to the therapeutic mAb OKT3